Chromosomal translocation products engender new intracellular therapeutic technologies.
Chromosomal translocations occur in leukemias, lymphomas, sarcomas and some epithelial tumors and some generate unique fusion proteins. These translocation products may provide tumor-specific targets for the development of new therapeutic strategies tailored to a malignant cell.
Hoofdauteurs: | Rabbitts, T, Stocks, MR |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2003
|
Gelijkaardige items
-
Chromosomal translocation master genes, mouse models and experimental therapeutics.
door: Rabbitts, T
Gepubliceerd in: (2001) -
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
door: Pérez-Martínez, D, et al.
Gepubliceerd in: (2010) -
Mouse models of human chromosomal translocations and approaches to cancer therapy.
door: Rabbitts, T, et al.
Gepubliceerd in: (2001) -
The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism.
door: Collins, E, et al.
Gepubliceerd in: (2002) -
The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.
door: Nam, C, et al.
Gepubliceerd in: (2006)